Literature DB >> 27830385

Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013).

Mario Pedrazzoni1, Andrea Giusti2, Giuseppe Girasole3, Barbara Abbate4, Ignazio Verzicco4, Gianfranco Cervellin5.   

Abstract

The aim of this study was to determine the incidence of atypical femoral fractures (AFFs) seen in a large emergency department in Italy. It was a retrospective study of all men and women aged 40 years or older admitted to the Emergency Department of Parma University Hospital for a femoral fracture. Cases were identified in the hospital database with use of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 820 or 821 or text strings. All the radiographic images of fractures not clearly identified as proximal or condylar were retrieved and evaluated by three independent reviewers. Fractures were considered as atypical if all three reviewers agreed on at least four of five major features defined by the 2013 American Society for Bone and Mineral Research criteria. In the 7-year period (2007-2013), with a total follow-up of 1,383,154 patient-years, we found 22 AFFs in 21 patients, accounting for 7.1% of low-trauma subtrochanteric/femoral shaft fractures and 0.6% of all femoral fractures. The incidence was very low (1.6 in 100,000 patient-years in both sexes combined). In contrast, the incidence of classic fractures of the proximal end of the femur was at least two orders of magnitude higher (typical/atypical rate ratio 152). Bisphosphonate use was reported in 13 patients (62%; mean treatment duration 9 years; range 5-14 years). Among 286 patients with typical subtrochanteric/femoral shaft fractures, 20 were being treated with bisphosphonate (7%; odds ratio 22; 95% confidence interval 8-58; p < 0.001). This study confirms the very low incidence of AFFs in the largest Italian cohort of patients to date. Even though the risk is higher in patients treated with bisphosphonates, AFFs are very rare, and typical femoral fractures are at least 100-fold more frequent.

Entities:  

Keywords:  Atypical femoral fractures; Bisphosphonates; Epidemiology; Osteoporosis

Year:  2016        PMID: 27830385     DOI: 10.1007/s00774-016-0790-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  31 in total

1.  Atypical femoral fractures, bisphosphonates, and mechanical stress.

Authors:  Per Aspenberg; Jörg Schilcher
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

2.  Atrophic femoral nonunion successfully treated with teriparatide.

Authors:  S Giannotti; V Bottai; G Dell'Osso; G de Paola; E Pini; G Guido
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-12-09

3.  Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Authors:  Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos
Journal:  Bone       Date:  2010-12-31       Impact factor: 4.398

Review 4.  Epidemiology and Postoperative Outcomes of Atypical Femoral Fractures in Older Adults: A Systematic Review.

Authors:  K S F Khow; P Shibu; S C Y Yu; M J Chehade; R Visvanathan
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

Review 6.  Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies.

Authors:  Andrea Giusti; Neveen A T Hamdy; Socrates E Papapoulos
Journal:  Bone       Date:  2010-05-20       Impact factor: 4.398

7.  Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls.

Authors:  Jörg Schilcher; Veronika Koeppen; Jonas Ranstam; Ralf Skripitz; Karl Michaëlsson; Per Aspenberg
Journal:  Bone       Date:  2012-10-22       Impact factor: 4.398

Review 8.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

9.  Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Authors:  B A Lenart; A S Neviaser; S Lyman; C C Chang; F Edobor-Osula; B Steele; M C H van der Meulen; D G Lorich; J M Lane
Journal:  Osteoporos Int       Date:  2008-12-09       Impact factor: 4.507

10.  Risk of atypical femoral fracture during and after bisphosphonate use.

Authors:  Jörg Schilcher; Veronika Koeppen; Per Aspenberg; Karl Michaëlsson
Journal:  Acta Orthop       Date:  2015-01-13       Impact factor: 3.717

View more
  3 in total

1.  Atypical subtrochanteric fractures in Korean hip fracture study.

Authors:  Y-K Lee; T-Y Kim; Y-C Ha; S-H Song; J W Kim; H C Shon; J S Chang; K-H Koo
Journal:  Osteoporos Int       Date:  2017-06-14       Impact factor: 4.507

2.  Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.

Authors:  J H Koh; J P Myong; J Yoo; Y-W Lim; J Lee; S-K Kwok; S-H Park; J H Ju
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

3.  The Genetics of Atypical Femur Fractures-a Systematic Review.

Authors:  Wei Zhou; Jeroen G J van Rooij; Peter R Ebeling; Annemieke J M H Verkerk; M Carola Zillikens
Journal:  Curr Osteoporos Rep       Date:  2021-02-15       Impact factor: 5.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.